AIM ImmunoTech (AIM) Revenue (2010 - 2026)
AIM ImmunoTech's Revenue was $26,000 in Q2 2026, up 4.0% from $25,000 a year earlier and up 18.2% from the prior quarter.
Powered by 
Analysis
AIM ImmunoTech (AIM) Revenue (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, AIM ImmunoTech's Revenue was $95,000 through Jun 30, 2026, down 21.5% year-over-year; for FY2025, it came in at $88,000, down 48.2% from FY2024.
- Revenue shows a five-year compound annual growth rate of -11.6% (FY2020 to FY2025).
- In earlier years, Revenue was $170,000 in FY2024 (-15.8%), $202,000 in FY2023 (+43.3%), $141,000 in FY2022 (+4.4%) and $135,000 in FY2021 (-17.2%).
- Quarterly Revenue has moved between $16,000 (Q1 2025) and $65,000 (Q4 2023) over five years.
- Compared with a year earlier, Revenue was higher in two of the last eight quarters, with an average decline of 25.3%.
- The best year-over-year quarter for Revenue over five years was Q3 2023 (growth of 119.0%); the worst was Q1 2025 (a decline of 60.0%).
- Per Business Quant data, AIM's Revenue in the three quarters before Q2 2026 was $22,000 (Q1 2026), $21,000 (Q4 2025) and $26,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | AIM ImmunoTech | 3.08 Mn | -18.22 Mn | 21,000.00 | 26,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26,000.00 |
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | 21,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 45,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 50,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 65,000.00 |
| Sep 30, 2023 | 46,000.00 |
| Jun 30, 2023 | 42,000.00 |
| Mar 31, 2023 | 49,000.00 |
| Dec 31, 2022 | 56,000.00 |
| Sep 30, 2022 | 21,000.00 |
| Jun 30, 2022 | 30,000.00 |
| Mar 31, 2022 | 33,000.00 |
| Dec 31, 2021 | 50,000.00 |
| Sep 30, 2021 | 33,000.00 |
API Access
AIM ImmunoTech Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();